C Bokemeyer
Overview
Explore the profile of C Bokemeyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
333
Citations
4856
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Brauneck F, Haag F, Woost R, Wildner N, Tolosa E, Rissiek A, et al.
Oncoimmunology
. 2021 Jul;
10(1):1930391.
PMID: 34211801
The inhibitory receptor TIGIT, as well as theectonucleotidases CD39 and CD73 constitute potential exhaustion markers for T cells. Detailed analysis of these markers can shed light into dysregulation of the...
12.
von Amsberg G, Sehovic M, Hartmann M, Bokemeyer C
Urologe A
. 2021 Jun;
60(7):872-879.
PMID: 34185119
Background: Rare tumors of the testis not originating from germinal epithelium are a diagnostic and therapeutic challenge. Objectives: To present current approaches in rare tumors of the testis using the...
13.
Aapro M, Lyman G, Bokemeyer C, Rapoport B, Mathieson N, Koptelova N, et al.
ESMO Open
. 2021 Jan;
6(1):100038.
PMID: 33421735
Cancer care has been profoundly impacted by the global pandemic of severe acute respiratory syndrome coronavirus 2 disease (coronavirus disease 2019, COVID-19), resulting in unprecedented challenges. Supportive care is an...
14.
Rammensee H, Loffler M, Walz J, Bokemeyer C, Haen S, Gouttefangeas C
Internist (Berl)
. 2020 May;
61(7):690-698.
PMID: 32462251
Tumor cells always exhibit differences to normal cells. These differences can be recognized by the immune system, enabling the destruction of tumor cells by T cells, as was impressively demonstrated...
15.
Waizenegger J, Ben-Batalla I, Weinhold N, Meissner T, Wroblewski M, Janning M, et al.
Leukemia
. 2020 Mar;
34(9):2542.
PMID: 32127637
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
16.
Salchow J, Mann J, Koch B, von Grundherr J, Jensen W, Elmers S, et al.
BMC Cancer
. 2020 Jan;
20(1):16.
PMID: 31906955
Background: Improved, multimodal treatment strategies have been shown to increase cure rates in cancer patients. Those who survive cancer as a child, adolescent or young adult (CAYA), are at a...
17.
Oing C, Skowron M, Bokemeyer C, Nettersheim D
Andrology
. 2019 Mar;
7(4):487-497.
PMID: 30924611
Background: Type II germ cell tumors represent the most common solid malignancy in men aged 15-45 years. Despite high cure rates of >90% over all stages, 10-15% of advanced patients...
18.
Schriefer P, Hartmann M, Oechsle K, Meyer C, Klutmann S, Fisch M, et al.
Urologe A
. 2018 Oct;
58(4):418-423.
PMID: 30374517
Background: Conventional radiographic imaging may fail to safely distinguish clinical stage I from stage IIA germ cell cancer, to localize isolated tumor marker relapses, and to equivocally identify the viability...
19.
Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines
Aapro M, Beguin Y, Bokemeyer C, Dicato M, Gascon P, Glaspy J, et al.
Ann Oncol
. 2018 Oct;
29(Suppl 4):iv271.
PMID: 30285221
No abstract available.
20.
Honecker F, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, et al.
Ann Oncol
. 2018 Aug;
29(8):1658-1686.
PMID: 30113631
The European Society for Medical Oncology (ESMO) consensus conference on testicular cancer was held on 3-5 November 2016 in Paris, France. The conference included a multidisciplinary panel of 36 leading...